Morgellons studies appear to reach opposite conclusions. The CDC-supported investigation identified ordinary environmental material and no common infectious cause. Filament-focused papers described biological structures associated with skin tissue and reported evidence of Borrelia. Psychiatric literature frequently classifies Morgellons as delusional infestation. These findings may conflict partly because the studies did not consistently examine the same patients, specimens or definition of Morgellons disease.
Every Morgellons investigation begins by deciding who qualifies as a case. That decision determines which patients enter the study, which materials are analyzed and what the results can reasonably establish. A population defined by self-reported fibers is not necessarily equivalent to one selected for filaments considered embedded in or projecting from tissue. A psychiatric referral population is different again.
This does not mean that every interpretation is equally supported. It means the evidence must be judged within the boundaries of each study. Until researchers establish reproducible diagnostic criteria and independent laboratories examine comparable specimens, the name “Morgellons” will continue to describe several overlapping—and potentially unrelated—clinical presentations.
The Case Definition Determines the Evidence
A case definition is the set of requirements used to decide whether someone belongs in a clinical investigation. It is not an administrative detail. It determines the population from which every observation and conclusion will be drawn.
A broad definition can capture the range of people seeking care, but it may combine unrelated conditions. A narrow definition may create a more uniform group, but it can exclude people who share symptoms without meeting a particular physical criterion. Neither approach is automatically wrong. They answer different research questions and should not be treated as interchangeable.
One patient may experience crawling sensations and find loose fibers on an irritated lesion. Another may have no infestation belief but appear to have a microscopic filament beneath unbroken skin. A third may have chronic excoriations and a fixed belief about synthetic organisms. A fourth may have eczema, neuropathic itch, medication-related formication, genuine infestation or another condition that has not yet been recognized.
All four might use the name Morgellons. That shared label does not establish that they have one disease. Combining them can obscure meaningful differences in dermatology, histology, microbiology, sensory symptoms, psychiatric findings and treatment response.
Embedded, Attached and Collected Do Not Mean the Same Thing
The word “fiber” conceals several different specimen categories. A loose strand presented in a container is not evidentially equivalent to a filament observed beneath intact skin. Material resting on an open lesion is not necessarily produced by the body. A strand caught in dried exudate may appear attached without having originated in tissue. A structure found in a biopsy section may be positioned along the surface or edge rather than integrated with living tissue.
Researchers should document whether material was loose, lying on the surface, trapped in scale-crust, introduced through a damaged barrier, or demonstrated histologically within tissue. They should also record whether the sampled skin was intact, ulcerated, infected, manipulated or actively healing.
Photography alone may not resolve the distinction. A structure can appear embedded when it is caught beneath a translucent crust or folded into a fissure. Histology provides better spatial information, but the biopsy must be collected and oriented so that the relationship between the structure and surrounding tissue is preserved.
The strongest evidence would document a filament in place before removal, demonstrate its relationship to intact tissue, characterize its composition through complementary methods and reproduce the finding under blinded conditions. Appropriate reference materials would include ordinary hair, textile fibers, wound dressings, keratin debris and specimens from other inflammatory or ulcerative skin disorders.
| Research approach | How participants may qualify | Primary question | Principal limitation |
|---|---|---|---|
| Population-based investigation | Self-reported fibers or materials with lesions or disturbing skin sensations | What characterizes the broader population reporting Morgellons-like symptoms? | May combine several conditions or dilute a rare filament-defined subgroup |
| Filament-focused study | Investigators select structures considered embedded in or projecting from tissue | What are these selected structures, and how are they related to skin? | Small, selected samples cannot establish prevalence, uniqueness or representativeness |
| Psychodermatology series | Referral for suspected delusional infestation or persistent beliefs involving fibers | What psychiatric and behavioral patterns occur in this clinical population? | Referral bias prevents automatic generalization to every fiber-associated presentation |
| Infectious or molecular study | Selected patients diagnosed with Morgellons, sometimes using filament criteria | Are particular organisms or microbial patterns detectable? | Detection does not establish causation, especially without independent replication and strong controls |
The CDC Investigation Used a Broad, Report-Based Definition
The largest and most frequently cited Morgellons investigation was conducted within Kaiser Permanente Northern California with support from the Centers for Disease Control and Prevention. Published in PLOS ONE in 2012, the researchers used the neutral term “unexplained dermopathy.”
A case was defined by the self-reported emergence of fibers or other materials from the skin accompanied by skin lesions, disturbing skin sensations or both. This was a practical definition for investigating a poorly understood public-health complaint. It did not require researchers to confirm a filament within or originating from tissue before a person qualified.
The investigators identified 115 people meeting the epidemiologic case definition, but only 41 received the clinical evaluation. Clinical findings varied substantially and were most consistent with excoriation or chronic irritation, sometimes accompanied by secondary infection. The study did not identify a consistent histopathologic pattern, parasite or common infectious cause.
What the CDC Actually Analyzed
The size of the study is often described imprecisely. Although 115 people met the case definition, the dedicated analysis of fibers and other materials collected from nonbiopsy skin sites involved 23 specimens obtained from only 12 participants.
In that 12-participant analysis, 83% of the specimens contained protein that the investigators considered likely to be superficial skin, while 43% contained cellulose consistent with cotton; some specimens contained both. Evidence of dyes was also found. Three specimens contained other recognizable materials: polyamide interpreted as probably nylon, cellulose nitrate with bismuth consistent with nail polish, and polyethylene described as possible contamination from a specimen-container lid.
The biopsy analysis was separate. Of the 41 clinically evaluated participants, 31 were considered to have lesions suitable for biopsy or material available for collection. Investigators obtained 62 biopsies: 37 from lesions, 22 from clinically normal skin and three from undocumented sites.
Birefringent material was detected in 16 of the 37 lesional biopsies. Most of it had spectral characteristics of cellulose compatible with cotton. In all but two specimens, the material was located within superficial scale-crust, along an edge, separate from the tissue or on the biopsy surface and produced no tissue reaction. This is the histologic version of an essential distinction: material visible in a section is not necessarily integrated with tissue.
The two exceptions showed foreign-body-type giant-cell reactions. One contained cellulose most consistent with cotton fragments, while the other contained a silicon-bearing material interpreted as likely silicate. Both sites showed evidence of previous ulceration or trauma, providing a plausible route through which foreign material could have crossed a damaged skin barrier.
Five of the 22 biopsies from clinically normal skin also contained cellulose fibers resembling cotton, positioned adjacent to or along the edge of the biopsy. None produced an accompanying tissue reaction. This within-study finding demonstrates that cotton can appear in skin specimens as background or processing-associated material without representing a disease-specific filament.
What the CDC Findings Can—and Cannot—Establish
The results support an environmental-material explanation for the specimens examined. The study did not report an unidentified material from its analyzed samples that required a novel biological explanation. It found the kinds of materials expected from superficial skin shedding, clothing, cosmetics and specimen contamination.
That finding cuts in both directions. A nonbiopsy material analysis involving 12 participants cannot prove that every reported Morgellons filament is cotton. Enrollment also did not require prior confirmation of a tissue-integrated filament. The study was therefore not designed to statistically exclude a rare subgroup defined by a reproducible filament phenotype.
However, the small specimen subset does not make its findings unimportant. Cotton, superficial skin protein, nylon, nail polish and container-associated plastic are exactly the types of findings predicted by environmental exposure and contamination. Any proposed biological-filament hypothesis must distinguish its specimens from those ordinary materials under stronger collection, comparison and contamination controls.
The full CDC-supported investigation should therefore be read neither as proof that every Morgellons claim is environmental nor as an irrelevant study of the wrong patients. It is substantial evidence about a broadly defined clinical population, bounded by the participants and materials actually examined.
Filament-Focused Studies Began With a Different Morgellons
A separate body of literature defines Morgellons more narrowly as a dermopathy involving filaments that lie beneath, are embedded in or project from skin. In this framework, crawling sensations, fatigue, patient-collected debris or a Lyme disease history are not sufficient by themselves. The proposed tissue-associated filament is treated as the defining objective feature.
A 2013 study by Middelveen and colleagues examined nonbiopsy dermatologic specimens from four women. The material included calluses with attached filaments collected after the participants had already been selected as meeting the authors’ clinical criteria. Using microscopy and histochemical methods, the investigators reported that some filaments contained keratin, collagen or melanin and proposed that the structures were produced by keratinocytes and fibroblasts rather than being ordinary textile fibers.
The 2013 filament-characterization paper therefore did not repeat the CDC investigation on a smaller scale. It began with selected patients and specimens that the researchers considered representative of a particular phenotype.
This difference can help explain how one study identified cotton and superficial skin material while another described biological components. The specimens were not obtained from equivalent populations, selected by equivalent criteria or necessarily collected from equivalent positions in relation to the skin.
Nevertheless, identifying keratin or collagen does not establish a unique disease. Both are normal components of skin, hair and wound repair. Their presence must be interpreted in relation to tissue architecture, lesion history, collection methods and comparison specimens from people with other skin disorders.
The study’s four-person sample can support a hypothesis that particular structures deserve further examination. It cannot establish how common those structures are, whether they are unique to Morgellons, whether the collected calluses demonstrate production within living tissue or whether the findings represent the broader population using the Morgellons label.
For a closer examination of filament morphology and composition claims, see Morgellons Fibers: What the Research Shows.
Repeated Publication Is Not Independent Replication
A major limitation deserves more weight than it commonly receives: much of the published evidence supporting biological filament production and a Borrelia association comes from a small, interconnected research network, with recurring investigators appearing across multiple papers.
Repeated publication by the same group can develop a hypothesis, refine laboratory methods and add new cases. It is not equivalent to independent replication. The same assumptions about diagnosis, specimen selection, laboratory interpretation and causation may carry from one paper into the next.
This does not demonstrate that the reported findings are false, but it limits how much confidence can be gained merely from counting the number of publications. Several papers from one connected network do not provide the same evidentiary strength as comparable results reproduced by unaffiliated investigators using preregistered criteria and blinded analysis.
Independent replication is particularly important when findings depend on subjective specimen selection, uncommon laboratory methods or interpretation of structures that could have multiple explanations. Until outside laboratories reproduce both the proposed filament phenotype and associated microbial findings, consistency within the original research network should be described as continuity of a hypothesis rather than confirmation by the field.
Psychiatric Studies Often Begin With Referral Bias
Another portion of the literature approaches Morgellons through delusional infestation. These clinical reports commonly involve patients referred to dermatology, psychodermatology or psychiatry because they maintain beliefs about fibers, parasites or foreign materials despite previous negative evaluations.
Within that population, researchers may find fixed beliefs, repeated specimen presentation, skin manipulation, depression, anxiety, social withdrawal or improvement following psychiatric treatment. These findings matter. Delusional infestation is a real condition, and psychiatric care can be appropriate even when a patient also has genuine physical symptoms.
The limitation is referral bias. A psychodermatology clinic does not receive a random sample of everyone with unexplained fiber-associated skin findings. It disproportionately receives people whose beliefs, behavior or prior clinical history caused another provider to suspect a psychiatric disorder.
Such a population is useful for studying delusional infestation but cannot automatically establish that every proposed filament-associated presentation is psychiatric. The same caution applies in reverse to specialty Lyme or Morgellons clinics, which may receive patients already committed to an infectious explanation.
Observation and interpretation must also be separated. A patient may correctly observe cotton in a wound but incorrectly identify it as a parasite. Another may have a genuine dermatologic lesion while developing an unsupported theory about its cause. A third may report a filament without holding any fixed infestation belief.
A mistaken explanation does not make every physical observation imaginary. A real lesion or visible structure likewise does not validate the patient’s explanation for its cause. Research becomes circular when a delusion is inferred from the fiber report itself and then used to prove that the reported fiber cannot deserve examination.
This distinction is explored further in Morgellons or Delusional Infestation? Investigating the Difference.
Demonstrating a Filament Would Not Prove an Infection
Even if researchers independently confirmed a reproducible biological filament phenotype, determining its cause would require separate evidence. The existence of a structure and the cause of that structure are not the same scientific question.
Several publications from the connected filament-research network have reported associations between Morgellons and Borrelia. These studies used combinations of silver staining, immunohistochemistry, PCR, culture and other molecular methods. A 2016 paper described Morgellons as a “filamentous borrelial dermatitis” and reported evidence interpreted as Borrelia in specimens from its selected participants.
Detection does not by itself demonstrate causation. Researchers must determine whether an organism is more common in cases than appropriate controls, whether it localizes to the relevant pathology, whether the finding can be reproduced independently and whether its presence predicts the development or course of the proposed phenotype.
Control selection is especially important because skin is not sterile. Microbial DNA can reflect infection, colonization, transient environmental exposure, reagents or contamination introduced during collection and processing. Increasing analytical sensitivity makes negative controls, extraction blanks and confirmatory testing more—not less—important.
The available evidence has not established one infectious cause across the broad population called Morgellons. Positive findings in small selected series do not prove that all Morgellons is Lyme disease. Negative findings in a broadly defined population do not exclude every infection from every individual or potential subgroup.
For a broader discussion of diagnostic overlap, see Morgellons Isn’t Always Lyme Disease.
What the 2026 Metagenomic Preprint Found
A 2026 preprint used deep metagenomic sequencing to compare Morgellons lesion material with unaffected skin samples from five related individuals in a family cohort. The investigators reported that lesion samples contained sequences poorly represented in existing databases and that metagenome-assembled genomes recovered from lesions differed taxonomically from those recovered from unaffected skin.
The authors also reported a phylogenetically structured microbial signature associated with lesion samples and proposed that some detected sequences might encode poorly characterized functions. These are more specific findings than simply saying the study discovered “microbial differences.” They present a testable hypothesis that lesion-associated microbial communities may differ from unaffected skin within this cohort.
The results remain difficult to interpret causally. Five related participants do not represent an independent or diverse clinical population. Family members can share genetics, environment, products, household microbes and specimen-handling practices. Lesions also differ biologically from unaffected skin because wounds, inflammation, moisture, topical treatments and disrupted barriers can alter microbial communities regardless of what initiated the lesion.
The study did not identify one organism established as the cause of Morgellons, and metagenomic detection cannot determine on its own whether a microbial community caused a lesion, colonized it afterward or appeared because of differences in collection and tissue state. The work is also a preprint and had not completed formal peer review when first posted.
The 2026 Morgellons metagenomic preprint is therefore best treated as hypothesis-generating evidence that warrants replication in larger, unrelated cohorts with matched collection methods and disease controls.
Heterogeneity May Be an Obstacle—or Part of the Answer
The case-definition argument carries an assumption that must be acknowledged. It is possible that better criteria will isolate a reproducible biological subgroup. It is also possible that no distinct Morgellons-specific phenotype will emerge.
A skeptic can reasonably argue that more than two decades without a group-independent, reproducible filament phenotype is itself evidence against Morgellons representing a distinct organic disease. Under that interpretation, heterogeneity is not merely a methodological problem hiding a rare entity. It may indicate that the Morgellons label combines familiar dermatologic, neurologic, environmental and psychiatric presentations without one unique underlying disorder.
The existing filament studies have not yet overcome that objection because their samples are small, selection is narrow and independent replication remains limited. Repeated calls for better criteria cannot become a way to protect a hypothesis indefinitely from negative evidence.
The opposing possibility also remains testable. A rare filament-defined subgroup could be diluted within broad report-based populations and missed by studies not requiring the proposed feature at enrollment. Failure to find that subgroup in a heterogeneous sample would not be equivalent to testing a well-defined subgroup and finding that the feature cannot be reproduced.
A rigorous study must therefore be capable of supporting either conclusion. It should be designed so that it can confirm a reproducible subgroup if one exists or provide strong evidence that the proposed distinguishing phenotype cannot be validated.
What Better Morgellons Research Would Require
A stronger multicenter study should not place every participant into one category solely because that person identifies as having Morgellons. Researchers should document the presenting phenotype first and assign participants to predefined groups before laboratory analysis.
One group could include patients with filaments demonstrated histologically within or arising from tissue. Another could include people reporting fibers without confirmation of tissue involvement. Comparison populations should include chronic excoriations, eczema, prurigo nodularis, neuropathic itch, delusional infestation, ordinary chronic wounds and healthy skin.
Specimen collection should be standardized and performed clinically. Researchers should record whether skin is intact, ulcerated, crusted, infected or manipulated. Suspected filaments should be photographed in place, and biopsies should preserve their relationship to surrounding tissue. Affected and unaffected skin from the same participant should be compared with anatomically matched samples from control groups.
Pathologists and laboratory personnel should be blinded to participant group whenever practical. Suspected filaments should be compared with ordinary hair, superficial skin protein, textile material, cosmetics, wound dressings and structures found in other skin disorders. Composition, morphology and histologic position should be evaluated through complementary methods rather than color or visual resemblance alone.
Molecular testing should include extraction blanks, environmental samples, reagent controls and independent confirmation of important positive findings. Investigators should distinguish microbial detection from infection and infection from proof that an organism caused the proposed filament phenotype.
The clinical evaluation should document dermatologic, neurologic, infectious, medication-related and psychiatric factors without assuming that one domain explains every presentation. Psychiatric evaluation can provide useful evidence without replacing specimen analysis. Microbial testing can also contribute without treating every detected organism as causative.
Finally, investigators should preregister their case definitions and primary outcomes, publish negative findings and provide enough methodological detail for independent replication. The 2025 review of Morgellons evidence similarly identified the absence of standardized criteria, biomarkers, clinical endpoints and Morgellons-specific randomized treatment trials as central barriers to progress.
Conclusion
The Morgellons controversy cannot be resolved by choosing a favorite paper. The CDC-supported investigation provides meaningful evidence that superficial skin material, cotton and other environmental substances occur in broadly defined Morgellons-like presentations. Its dedicated nonbiopsy material analysis was nevertheless limited to 23 specimens from 12 participants and did not enroll a population defined by independently confirmed tissue-integrated filaments.
Filament-focused studies reported biological components in selected nonbiopsy dermatologic specimens, but their samples were small and much of the supporting literature arose from a connected research network without sufficient independent replication. Psychiatric studies demonstrate that delusional infestation explains some presentations, but referral-selected populations cannot automatically define every person reporting a filament.
Standardized criteria might reveal a reproducible subgroup, or they might demonstrate that Morgellons does not represent one distinct organic disease. Both outcomes must remain scientifically possible. The next generation of research should define the patient and specimen before attempting to explain the disease—and should be designed to disprove, not merely preserve, its preferred hypothesis.
Frequently Asked Questions
Why do Morgellons studies reach different conclusions?
Morgellons studies do not consistently use the same case definition. Some enroll people who report fibers or disturbing skin sensations, while others select specimens considered embedded in or projecting from tissue. Psychiatric and infectious-disease studies may begin with still different referral populations. Their findings cannot be compared as though all participants had the same presentation.
Did the CDC prove that all Morgellons fibers are cotton?
No. The dedicated nonbiopsy material analysis examined 23 specimens from 12 participants. The materials commonly contained superficial skin protein, cellulose consistent with cotton or both, along with several other recognizable environmental substances. Cotton-like cellulose was also found along the edges of five clinically normal skin biopsies without a tissue reaction. These findings strongly demonstrate that environmental material occurs in Morgellons-like presentations, but they do not chemically identify every reported filament.
Have studies proven that Morgellons fibers are produced by the body?
Small filament-focused studies have reported structures containing keratin, collagen or melanin and proposed that they were produced by skin cells. Those findings have not yet been independently reproduced using standardized enrollment, blinded analysis and appropriate disease controls. Keratin and collagen are also ordinary biological components, so their presence alone does not establish a unique disease.
Has Morgellons been proven to be caused by Lyme disease?
No. A connected group of researchers has reported associations between filament-defined Morgellons and Borrelia, but independent evidence has not established that Lyme disease causes all—or most—presentations using the Morgellons label. Microbial detection must be reproduced in controlled studies and shown to have a causal relationship with the proposed skin phenotype.
Does the lack of a consistent Morgellons definition support skepticism?
Yes. The continued absence of a group-independent, reproducible phenotype is evidence that must count against the claim of one distinct organic disease. It is not conclusive, because broad definitions may dilute a rare subgroup, but standardized research must be capable of showing that no unique subgroup exists rather than assuming that better criteria will eventually confirm one.
Selected Sources
- Pearson ML, et al. Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy. PLOS ONE. 2012.
- Middelveen MJ, et al. Characterization and Evolution of Dermal Filaments From Patients With Morgellons Disease. Clinical, Cosmetic and Investigational Dermatology. 2013.
- Middelveen MJ, et al. Morgellons Disease: A Filamentous Borrelial Dermatitis. International Journal of General Medicine. 2016.
- Akbarialiabad H, et al. Morgellons Disease: A Review on Current Evidence and the Need for Consensus, Standardized Criteria, and Future Randomized Controlled Trials. Archives of Dermatological Research. 2025.
- Lambert AN, Kindschuh W. Metagenomics Reveals a Phylogenetically Informed Microbial Signature Associated With Morgellons Disease. bioRxiv preprint. 2026.
MorgellonsSurvey.org provides research education and patient advocacy. This article does not diagnose disease or recommend a particular medical treatment. People with unexplained skin lesions, persistent sensations or possible infection should seek evaluation from a qualified healthcare professional.
